119 related articles for article (PubMed ID: 1808120)
1. Preclinical characterization of iopromide-carrying liposomes.
Krause W; Sachse A; Wagner S; Kollenkirchen U; Rössling G
Invest Radiol; 1991 Nov; 26 Suppl 1():S172-4; discussion S175-6. PubMed ID: 1808120
[No Abstract] [Full Text] [Related]
2. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging.
Leike JU; Sachse A; Rupp K
Invest Radiol; 2001 Jun; 36(6):303-8. PubMed ID: 11410749
[TBL] [Abstract][Full Text] [Related]
3. Iopromide-carrying liposomes as a contrast agent for the liver.
Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
[No Abstract] [Full Text] [Related]
4. Preclinical testing of iopromide. 2nd communication: toxicological evaluation.
Krause W; Schöbel C; Press WR
Arzneimittelforschung; 1994 Nov; 44(11):1275-9. PubMed ID: 7848345
[TBL] [Abstract][Full Text] [Related]
5. Characterization of iopromide liposomes.
Krause W; Leike J; Sachse A; Schuhmann-Giampieri G
Invest Radiol; 1993 Nov; 28(11):1028-32. PubMed ID: 8276573
[TBL] [Abstract][Full Text] [Related]
6. CT imaging with iopromide liposomes in a rabbit model.
Krause W; Schönborn A; Rupp K
J Liposome Res; 2011 Sep; 21(3):229-36. PubMed ID: 21039317
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection.
Sachse A; Leike JU; Rössling GL; Wagner SE; Krause W
Invest Radiol; 1993 Sep; 28(9):838-44. PubMed ID: 8225891
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.
Sachse A; Leike JU; Schneider T; Wagner SE; Rössling GL; Krause W; Brandl M
Invest Radiol; 1997 Jan; 32(1):44-50. PubMed ID: 9007647
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of iopromide.
Krause W
Invest Radiol; 1994 May; 29 Suppl 1():S21-32. PubMed ID: 8071040
[No Abstract] [Full Text] [Related]
10. Vertebral artery injections of methylglucamine diatrizoate 60%, iopromide, and iotrolan in the rabbit.
Thomson KR; Wells DG; O'Brien K; Tomkins DC; Dixon RG
Invest Radiol; 1990 Sep; 25 Suppl 1():S88-9. PubMed ID: 2283270
[No Abstract] [Full Text] [Related]
11. Neurotolerability of nonionic X-ray contrast media. The role of chemotoxicity.
Luzzani F; Morisetti A; Bussi S; Tirone P; de Haën C
Invest Radiol; 1996 Jun; 31(6):338-44. PubMed ID: 8761866
[TBL] [Abstract][Full Text] [Related]
12. The rabbit renal toxicity test: a sensitive in vivo test for the nephrotoxicity of contrast agents.
Pettersson G; Towart R; Grant D; Thyberg K; Golman K
Acad Radiol; 2002 May; 9 Suppl 1():S62-4. PubMed ID: 12019897
[No Abstract] [Full Text] [Related]
13. [Comparison of different contrast medium boluses in rapid dynamic CT studies].
Zwicker C; Hering M; Langer R
Rontgenpraxis; 1997 Apr; 50(4):77-82. PubMed ID: 9182334
[No Abstract] [Full Text] [Related]
14. Percutaneous CT lymphography using a new polyiodinated biomimetic microemulsion.
Wisner ER; Weichert JP; Longino MA; Counsell RE; Weisbrode SE
Acad Radiol; 2002 May; 9 Suppl 1():S191-3. PubMed ID: 12019865
[No Abstract] [Full Text] [Related]
15. Biodistribution and imaging characteristics of iotrolan-carrying interdigitation-fusion vesicles.
Seltzer SE; Janoff AS; Blau M; Adams DF; Minchey SR; Boni LT
Invest Radiol; 1991 Nov; 26 Suppl 1():S169-71; discussion S175-6. PubMed ID: 1808119
[No Abstract] [Full Text] [Related]
16. Neurotoxicity of non-ionic X-ray contrast media after intracisternal administration in rats.
Wible JH; Barco SJ; Scherrer DE; Wojdyla JK; Adams MD
Eur J Radiol; 1995 Mar; 19(3):206-11. PubMed ID: 7601172
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of iopromide liposomes in rabbits.
Schuhmann-Giampieri G; Leike J; Sachse A; Krause W
Pharm Res; 1995 Jul; 12(7):1065-71. PubMed ID: 7494804
[TBL] [Abstract][Full Text] [Related]
18. Liver contrast enhancement in primates using iopromide liposomes.
Schmiedl UP; Krause W; Leike J; Nelson JA; Schuhmann-Giampieri G
Acad Radiol; 1995 Nov; 2(11):967-72. PubMed ID: 9419668
[TBL] [Abstract][Full Text] [Related]
19. Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment.
Li C; McCuskey P; Yang DJ; Kan Z; Wallace S
Acad Radiol; 1996 Aug; 3 Suppl 2():S227-8. PubMed ID: 8796568
[No Abstract] [Full Text] [Related]
20. Contrast timing in computed tomography: effect of different contrast media concentrations on bolus geometry.
Mahnken AH; Jost G; Seidensticker P; Kuhl C; Pietsch H
Eur J Radiol; 2012 Apr; 81(4):e629-32. PubMed ID: 22297184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
